MedicQuant was established in 2019 and is a spin-out from iNANO, Aarhus University. MedicQuant is an in vitro diagnostic (IVD) company developing a platform that measures drug levels rapidly, directly from whole blood and at the point-of-care to provide clinicians with the answers they need when minutes matter. MedicQuant’s first product measures new anticoagulant drugs at the point-of-care to provide clinicians with the answers needed for rapid and life-saving management of stroke patients, saving lives and improving outcome.
